Skip to main content

Table 5 Univariate and multivariate logistic regression analyses of predictive factors for recurrence and death

From: Differences in clinical outcomes according to the time interval between the bridge to surgery stenting and surgery for left-sided malignant colorectal obstruction

  Recurrence Death
Uni-variate analysis Multi-variate analysis Uni-variate analysis Multi-variate analysis
HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
Male sex 0.855 (0.406–1.799) 0.680    0.846 (0.421–1.702) 0.639   
Age, years 0.980 (0.952–1.009) 0.175    1.037 (1.005–1.069) 0.022 1.047 (1.000–1.096) 0.044
ASA 3–4 0.381 (0.082–1.760) 0.216 0.186 (0.022–1.586) 0.124 0.690 (0.210–2.265) 0.541   
Preoperative serum CEA, ng/ml 1.029 (1.004–1.054) 0.020 1.024 (0.995–1.053) 0.101 1.035 (1.009–1.061) 0.009 1.027 (0.991–1.063) 0.142
Interval from SEMS to resection, days 0.977 (0.939–1.017) 0.252    1.012 (0.978–1.047) 0.492   
Stoma directly after resection 2.879 (0.967–8.573) 0.057    5.189 (1.662–16.202) 0.005 6.617 (1.287–34.009) 0.024
Adjuvant chemotherapy 0.579 (0.248–1.351) 0.579 0.404 (0.149–1.094) 0.075 0.218 (0.096–0.496) <0.001 0.151 (0.044–0.515) 0.003
Overall pathologic stage III 4.183 (1.761–9.935) 0.001    2.888 (1.365–6.107) 0.006 5.243 (1.548–17.757) 0.008
PD/Mucinous cancer 4.629 (0.743–28.835) 0.101    9.302 (1.010–85.672) 0.049 9.835 (0.770–125.638) 0.079
Metastatic LN, n 1.385 (1.172–1.636) <0.001 1.387 (1.155–1.666) <0.001 1.172 (1.046–1.313) 0.006 1.185 (1.004–1.400) 0.045
Lymphovascular invasion 2.337 (1.058–5.161) 0.036    1.054 (0.699–3.234) 0.296   
Perineural invasion 3.692 (1.426–9.559) 0.007    1.027 (0.495–2.131) 0.942 0.271 (0.093–0.790) 0.017
  1. ASA American Society of Anesthesiologists, CEA Carcinoembryonic antigen, SEMS Self-expandable metal stent, PD Poorly differentiated, LN Lymph node, HR Hazard ratio